Product
Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cells Product
1 clinical trial
1 indication
Indication
Musculoskeletal InjuryClinical trial
A Patient Sponsored Ongoing Open-label Single-arm, Safety and Efficacy, Phase I/IIb Study of Cellcolabs´ Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or DegenerationStatus: Recruiting, Estimated PCD: 2027-10-19